CSTL

Castle Biosciences (CSTL)

Castle Biosciences Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CSTL

<< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >>

Date	Time	Source	Headline	Symbol	Company
07/11/2024	12:21PM	iHub Newswire	FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
03/19/2024	7:00AM	Business Wire	Leading Squamous Cell Carcinoma Practitioners Publish Consensus Guidelines Integrating DecisionDx®-SCC into a Clinical Workflow to Improve Decision-Making Regarding the Use of Adjuvant Radiation Therapy	NASDAQ:CSTL	Castle Biosciences Inc
03/15/2024	4:30PM	Business Wire	New Study Shows that the Drug-Drug Interactions and Lifestyle Factors Provided by Castle Biosciences’ IDgenetix® Test Significantly Improve Medication Recommendations Over Drug-Gene Interactions Alone for Patients 65 and Older	NASDAQ:CSTL	Castle Biosciences Inc
03/12/2024	7:00AM	Business Wire	Castle Biosciences to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum	NASDAQ:CSTL	Castle Biosciences Inc
03/08/2024	4:30PM	Business Wire	Castle Biosciences to Present New Data Highlighting the Clinical Value of its Dermatologic Tests for Patients with Skin Cancer at the 2024 American Academy of Dermatology (AAD) Annual Meeting	NASDAQ:CSTL	Castle Biosciences Inc
03/07/2024	7:00AM	Business Wire	In Novel Cohort, New Data Confirms DecisionDx®-SCC Provides Significant, Independent and Clinically Actionable Risk-Stratification of Patients, Including in Various High-Risk Subgroups	NASDAQ:CSTL	Castle Biosciences Inc
03/06/2024	6:07PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CSTL	Castle Biosciences Inc
03/06/2024	6:04PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CSTL	Castle Biosciences Inc
03/06/2024	6:00PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CSTL	Castle Biosciences Inc
02/28/2024	5:15PM	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:CSTL	Castle Biosciences Inc
02/28/2024	4:05PM	Business Wire	Castle Biosciences Reports Fourth Quarter and Full-Year 2023 Results	NASDAQ:CSTL	Castle Biosciences Inc
02/26/2024	7:00AM	Business Wire	Study Finds DecisionDx®-Melanoma Significantly Improves the Risk Stratification of Patients with Stage I Melanoma Compared to American Joint Committee on Cancer 8th Edition Staging	NASDAQ:CSTL	Castle Biosciences Inc
02/07/2024	7:00AM	Business Wire	Castle Biosciences to Release Fourth Quarter and Full-Year 2023 Financial Results and Host Conference Call on Wednesday, Feb. 28, 2024	NASDAQ:CSTL	Castle Biosciences Inc
01/18/2024	7:00AM	Business Wire	New Study Highlights Significant Potential Medicare Savings Through Use of Castle Biosciences’ DecisionDx®-SCC Test to Guide Adjuvant Radiation Therapy Decisions in Patients with Cutaneous Squamous Cell Carcinoma	NASDAQ:CSTL	Castle Biosciences Inc
01/14/2024	4:30AM	Business Wire	Castle Biosciences Presents Data Supporting the Utility of Its Tests in the Clinical Care of Patients with Skin Cancers at the 2024 Winter Clinical Dermatology Conference - Hawaii®	NASDAQ:CSTL	Castle Biosciences Inc
01/09/2024	7:00AM	Business Wire	Castle Biosciences’ Chief Operating Officer Kristen Oelschlager Selected Among the Top 25 Women Leaders in Biotechnology by The Healthcare Technology Report	NASDAQ:CSTL	Castle Biosciences Inc
01/08/2024	7:04AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CSTL	Castle Biosciences Inc
01/07/2024	8:00PM	Business Wire	Castle Biosciences Announces Preliminary Fourth Quarter and Full-Year 2023 Results	NASDAQ:CSTL	Castle Biosciences Inc
01/04/2024	5:16PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CSTL	Castle Biosciences Inc
01/03/2024	4:11PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CSTL	Castle Biosciences Inc
12/20/2023	7:00AM	Business Wire	Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:CSTL	Castle Biosciences Inc
12/12/2023	7:39PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CSTL	Castle Biosciences Inc
12/12/2023	7:33PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CSTL	Castle Biosciences Inc
12/12/2023	7:28PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CSTL	Castle Biosciences Inc
12/04/2023	4:50PM	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:CSTL	Castle Biosciences Inc
12/01/2023	7:00AM	Business Wire	Study Finds Nurse Practitioners and Physician Assistants Would Alter Patient Care Decisions Based on DecisionDx®-Melanoma Test Results	NASDAQ:CSTL	Castle Biosciences Inc
11/14/2023	7:00AM	Business Wire	Castle Biosciences Announces Multiple Data Presentations at the 2023 American Society for Dermatologic Surgery Annual Meeting	NASDAQ:CSTL	Castle Biosciences Inc
11/13/2023	7:00AM	Business Wire	Castle Biosciences Ranked Among the Top Workplaces in Houston by the Houston Chronicle for the Third Consecutive Year	NASDAQ:CSTL	Castle Biosciences Inc
11/09/2023	5:25PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CSTL	Castle Biosciences Inc
11/08/2023	4:30PM	Business Wire	Real-World Evidence Confirms IDgenetix®-Guided Medication Management Significantly Improves Response and Remission Rates in Patients with Major Depressive Disorder	NASDAQ:CSTL	Castle Biosciences Inc